Literature DB >> 29704590

Protective influences of N-acetylcysteine against alcohol abstinence-induced depression by regulating biochemical and GRIN2A, GRIN2B gene expression of NMDA receptor signaling pathway in rats.

Rutuja Yawalkar1, Harish Changotra2, Girdhari Lal Gupta3.   

Abstract

Evidences have indicated a high degree of comorbidity of alcoholism and depression. N-acetylcysteine (NAC) has shown its clinical efficiency in the treatment of several psychiatric disorders and is identified as a multi-target acting drug. The ability of NAC to prevent alcohol abstinence-induced depression-like effects and underlying mechanism(s) have not been adequately addressed. This study was aimed to investigate the beneficial effects of NAC in the alcohol abstinence-induced depression developed following long-term voluntary alcohol intake. For evaluation of the effects of NAC, Sprague-Dawley rats were enabled to voluntary drinking of 4.5%, 7.5% and 9% v/v alcohol for fifteen days. NAC (25, 50, and 100 mg/kg) and fluoxetine (5 mg/kg) were injected intraperitoneally for three consecutive days during the alcohol abstinence period on the days 16, 17, 18. The behavioral studies were conducted employing forced swim test (FST), and tail suspension test (TST) on day 18 to determine the effects of N-acetylcysteine and fluoxetine in the ethanol withdrawal induced-depression. Blood alcohol concentration, alcohol biomarkers like SGPT, SGOT, ALP, GGT, and MCV were estimated by using commercially available kits. Serotonin concentrations were measured in the plasma, hippocampus and pre-frontal cortex using the rat ELISA kit. The expression of GRIN1, GRIN2A, GRIN2B genes for the N-methyl d-aspartate receptors (NMDAR) subunits in the hippocampus and the prefrontal cortex were also examined by reverse-transcription quantitative polymerase chain reaction. The results revealed that alcohol abstinence group depicted increased immobility time in FST and TST. Further, NAC exerted significant protective effect at the doses 50 mg/kg and 100 mg/kg, but 25 mg/kg showed insignificant protection against alcohol abstinence-induced depression. The increased level of biochemical parameters following ethanol abstinence were also reversed by NAC at the dose of 100 mg/kg. The significant reversal effect of NAC on the serotonin level following alcohol abstinence was greater in the hippocampus as compared to the third-day alcohol withdrawal group. The increased expression levels of GRIN2A and GRIN2B following ethanol abstinence were reversed with a higher dose of NAC (100 mg/kg) treatment. In conclusion, the results of the study reveal that NAC has remarkable protective effects in the alcohol abstinence-induced depression by modulating alcohol markers, serotonin levels and GRIN2A, GRIN2B gene expression of NMDAR signaling pathway in rats.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol abstinence; Alcohol markers; Depression; GRIN2A; GRIN2B; Gene expression; N-acetylcysteine

Mesh:

Substances:

Year:  2018        PMID: 29704590     DOI: 10.1016/j.neuint.2018.04.011

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

1.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) alleviates depression-like behavior and normalizes epigenetic changes in the hippocampus during ethanol withdrawal.

Authors:  Wei-Yang Chen; Huaibo Zhang; Eleonora Gatta; Elizabeth J Glover; Subhash C Pandey; Amy W Lasek
Journal:  Alcohol       Date:  2019-03-06       Impact factor: 2.405

2.  Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.

Authors:  Rachel L Tomko; Nathaniel L Baker; Caitlyn O Hood; Amanda K Gilmore; Erin A McClure; Lindsay M Squeglia; Aimee L McRae-Clark; Susan C Sonne; Kevin M Gray
Journal:  Psychopharmacology (Berl)       Date:  2019-11-11       Impact factor: 4.530

3.  Epigenetic mechanisms underlying stress-induced depression.

Authors:  Luana Martins de Carvalho; Wei-Yang Chen; Amy W Lasek
Journal:  Int Rev Neurobiol       Date:  2020-09-26       Impact factor: 3.230

4.  A standardized polyherbal preparation POL-6 diminishes alcohol withdrawal anxiety by regulating Gabra1, Gabra2, Gabra3, Gabra4, Gabra5 gene expression of GABAA receptor signaling pathway in rats.

Authors:  Lalit Sharma; Aditi Sharma; Ashutosh Kumar Dash; Gopal Singh Bisht; Girdhari Lal Gupta
Journal:  BMC Complement Med Ther       Date:  2021-01-06

5.  Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder.

Authors:  William R Reay; Michael P Geaghan; Joshua R Atkins; Vaughan J Carr; Melissa J Green; Murray J Cairns
Journal:  Am J Hum Genet       Date:  2022-09-01       Impact factor: 11.043

6.  Chronic N-acetylcysteine treatment improves anhedonia and cognition in a mouse model of the schizophrenia prodrome.

Authors:  Lukas Marius Bühner; Sampath K T Kapanaiah; Dennis Kätzel
Journal:  Front Behav Neurosci       Date:  2022-09-26       Impact factor: 3.617

7.  Phosphoproteomic profiling of the hippocampus of offspring rats exposed to prenatal stress.

Authors:  Qinghong Li; Dongge Cai; Huimei Huang; Huiping Zhang; Ruimiao Bai; Xiaolin Zhao; Hongli Sun; Pei Qin
Journal:  Brain Behav       Date:  2021-09-14       Impact factor: 2.708

Review 8.  N-acetylcysteine in substance use disorder: a lesson from preclinical and clinical research.

Authors:  Irena Smaga; Małgorzata Frankowska; Małgorzata Filip
Journal:  Pharmacol Rep       Date:  2021-06-06       Impact factor: 3.024

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.